Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
β€œThe incredibly small size of VIPR makes these systems transformative tools for genome engineering,” said Philip Kranzusch, a microbiologist at Harvard Medical School who was not involved in the research.
Simplified Text
Philip Kranzusch stated that the small size of VIPR makes the systems transformative tools for genome engineering.
Confidence Score
1.000
Claim Maker
Philip Kranzusch
Context Type
News Article
Context Details
{
    "person": "Philip Kranzusch",
    "system_name": "VIPR",
    "organization": "Harvard Medical School"
}
UUID
731d2dcf-3c02-4287-ac74-08b19fd3579b
Vector Index
βœ— No vector
Created
September 18, 2026 at 7:08 PM (3 weeks ago)
Last Updated
September 18, 2026 at 7:08 PM (3 weeks ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://nytimes.com/2026/09/17/science/crispr-gene-editing-vipr.html
25 claims πŸ”₯
3 weeks ago
https://nytimes.com/2026/09/17/science/crispr-gene-editing-vipr.html

Scientists have discovered VIPR, a powerful gene-targeting system in viruses that appears to predate CRISPR and may be even more effective. This ancient system, over four billion years old, could offer advantages over CRISPR due to its smaller size and wider targeting capabilities.

Similar Claims (5)

Other claims identified as semantically similar to this one.